Glucose lowering and vascular protective effects of cycloset added to GLP‐1 receptor agonists in patients with type 2 diabetes

OBJECTIVE: To determine the glucose‐lowering mechanism of action and the effects of a quick‐release bromocriptine‐QR, a D2‐dopamine agonist (Cycloset) on vascular function in patients with type 2 diabetes (T2D). STUDY DESIGN AND METHODS: Fifteen poorly controlled T2D treated with metformin plus gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Alatrach, Mariam, Agyin, Christina, Adams, John, Chilton, Robert, Triplitt, Curtis, DeFronzo, Ralph A., Cersosimo, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354804/
https://www.ncbi.nlm.nih.gov/pubmed/30815562
http://dx.doi.org/10.1002/edm2.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354804/
https://www.ncbi.nlm.nih.gov/pubmed/30815562
http://dx.doi.org/10.1002/edm2.34

Ejemplares similares